The landscape of blood sugar treatment is advancing with the introduction of transdermal GLP-1 delivery . These novel patches offer a possibly more comfortable alternative to shots for individuals living with diabetes 2. They deliver a GLP-1 agonist directly through the dermis , bypassing the req